ArticleJournal of pain research2023

Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.

Kazumasa Saigoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.